Actively Recruiting
Clinical Outcomes Following Group-based Family Cognitive-Behaviour Therapy in Pediatric Obsessive-Compulsive Disorder
Led by University of British Columbia · Updated on 2023-05-12
180
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of British Columbia
Lead Sponsor
M
Michael Smith Foundation for Health Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of Group-based Family Cognitive-Behavioural Therapy (GF-CBT) in children and youth diagnosed with moderate to severe Obsessive-Compulsive Disorder (OCD). This condition often begins in childhood and is under-diagnosed, with access to effective treatments like CBT and medications being challenging. The study compares clinical and neural outcomes between youth receiving GF-CBT and those on a waitlist without new treatment. Participants in the treatment group attend 12 GF-CBT group therapy sessions involving both the child and their family members. The control group consists of waitlist participants who do not receive new treatment during the study period. The study measures changes in OCD severity and functioning before and after the 12 sessions. Participants will be assessed at multiple time points: the treatment group at baseline, midpoint, after completing 12 sessions, and one month after treatment ends; the waitlist group at baseline and after a similar time delay. The primary outcome is measured by the Children's Yale Brown Obsessive-Compulsive Scale (CY-BOCS), which evaluates OCD severity. The study also tracks individual and family functioning changes, with all assessments conducted in English and involving caregiver consent.
CONDITIONS
Brief Title
Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female, aged 5-18 years old
- Ability of subject and parent to provide informed assent/consent
- English-speaking
- Current DSM IV-TR Axis I diagnosis of childhood-onset OCD; Moderate to severe OCD (CY-BOCS ≥16/40)
You will not qualify if you...
- Current diagnosis of bipolar disorder, psychosis, mental retardation or pervasive developmental disorder (e.g., autism)
- Current or past substance dependence/abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of 12 therapy sessions
Participants in Group 1 attend 12 group-based family cognitive-behavioural therapy sessions to treat pediatric OCD.
12 therapy sessions
Duration - Duration equivalent to 12 therapy sessions
Participants in Group 2 (waitlist control) are observed without receiving new treatment during this period.
2 visits (baseline and post-waitlist period)
Duration - 1 month
Participants in Group 1 are followed up one month after completing therapy to assess clinical outcomes.
1 follow-up visit
Trial Site Locations
Total: 1 location
1
BC Children's Hospital Research Institute
Vancouver, British Columbia, Canada
Actively Recruiting
Research Team
D
Diana Franco Yamin, MA
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here